Clinical Trial: Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Phase IV, Open-label, Multi-center, Community-based Trial Studying the Safety and Efficacy of Keppra™ as Adjunctive Therapy in Adult Subjects With Uncontrolled Partial Ep

Brief Summary:

Community based study assessing safety and efficacy of levetiracetam in partial onset seizures.

The optimal dose in daily clinical practice will be used.

Detailed Summary:
Sponsor: UCB Pharma

Current Primary Outcome: To assess safety of levetiracetam

Original Primary Outcome: Same as current

Current Secondary Outcome: To evaluate efficacy of levetiracetam in community based practice.

Original Secondary Outcome: Same as current

Information By: UCB Pharma

Dates:
Date Received: September 8, 2005
Date Started: November 2003
Date Completion:
Last Updated: November 14, 2013
Last Verified: July 2010